Trial Profile
A Phase 4 Study to Evaluate the Safety and Immunogenicity of Trivalent Oral Polio Vaccine in Healthy Polio Vaccinated Children 1 to 5 Years of Age and in Healthy Unvaccinated Infants at 6 Weeks of Age in the Dominican Republic
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Apr 2023
Price :
$35
*
At a glance
- Drugs Poliovirus vaccine (Primary)
- Indications Poliomyelitis
- Focus Adverse reactions
- Acronyms T2-ABMG
- 10 Jul 2017 Status changed from not yet recruiting to completed.
- 26 Oct 2015 New trial record